BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15966362)

  • 21. What role does the alpha-chain play in recognition of superantigens?
    Gascoigne NR
    Res Immunol; 1993; 144(3):184-7; discussion 214-22. PubMed ID: 7694343
    [No Abstract]   [Full Text] [Related]  

  • 22. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of T cells by superantigen in class II-negative mice.
    Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
    J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of emetic response to staphylococcal enterotoxins in the house musk shrew (Suncus murinus).
    Hu DL; Omoe K; Shimoda Y; Nakane A; Shinagawa K
    Infect Immun; 2003 Jan; 71(1):567-70. PubMed ID: 12496213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to tolerance induction in the diabetes-prone biobreeding rat as one manifestation of abnormal responses to superantigens.
    Sellins KS; Gold DP; Bellgrau D
    Diabetologia; 1996 Jan; 39(1):28-36. PubMed ID: 8720600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus.
    Jarraud S; Peyrat MA; Lim A; Tristan A; Bes M; Mougel C; Etienne J; Vandenesch F; Bonneville M; Lina G
    J Immunol; 2001 Jan; 166(1):669-77. PubMed ID: 11123352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superantigens as immunogens and tolerogens.
    Lobo-Yeo A; Lamb JR
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S17-21. PubMed ID: 8324944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
    Rich RR; Mollick JA; Cook RG
    Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CD8 T cell response to staphylococcal enterotoxins.
    Herrmann T; MacDonald HR
    Semin Immunol; 1993 Feb; 5(1):33-9. PubMed ID: 8467093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune response to staphylococcal superantigens.
    Krakauer T
    Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster.
    Thomas DY; Jarraud S; Lemercier B; Cozon G; Echasserieau K; Etienne J; Gougeon ML; Lina G; Vandenesch F
    Infect Immun; 2006 Aug; 74(8):4724-34. PubMed ID: 16861660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-1.
    Chatila T; Scholl P; Ramesh N; Trede N; Fuleihan R; Morio T; Geha RS
    Chem Immunol; 1992; 55():146-71. PubMed ID: 1418616
    [No Abstract]   [Full Text] [Related]  

  • 35. Staphylococcus-mediated T-cell activation and spontaneous natural killer cell activity in the absence of major histocompatibility complex class II molecules.
    Chapes SK; Hoynowski SM; Woods KM; Armstrong JW; Beharka AA; Iandolo JJ
    Infect Immun; 1993 Sep; 61(9):4013-6. PubMed ID: 8359928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Staphylococcus aureus enterotoxin L.
    Orwin PM; Fitzgerald JR; Leung DY; Gutierrez JA; Bohach GA; Schlievert PM
    Infect Immun; 2003 May; 71(5):2916-9. PubMed ID: 12704169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
    Norton SD; Schlievert PM; Novick RP; Jenkins MK
    J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of rat spleen cells by staphylococcal enterotoxins.
    Holbrook MR; Young KE; Gibbon LG; Webster CA; Tranter HS; Arbuthnott JP; Todd I
    FEMS Immunol Med Microbiol; 1993 Aug; 7(2):169-74. PubMed ID: 8401429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity in Staphylococcus aureus enterotoxins.
    Thomas D; Chou S; Dauwalder O; Lina G
    Chem Immunol Allergy; 2007; 93():24-41. PubMed ID: 17369698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.